LINC01006 and miR-3199 Serve as Novel Markers of Poor Prognosis in Colon Cancer and Regulate Cell Proliferation, Migration and Invasion
- PMID: 35210837
- PMCID: PMC8858767
- DOI: 10.2147/IJGM.S334701
LINC01006 and miR-3199 Serve as Novel Markers of Poor Prognosis in Colon Cancer and Regulate Cell Proliferation, Migration and Invasion
Abstract
Purpose: Colon cancer is the most commonly diagnosed gastrointestinal cancer. This research intended to evaluate the prognostic values of LINC01006 and miR-3199 for colon cancer and their effects on cell physiology.
Patients and methods: LINC01006 and miR-3199 expression levels were determined by RT-qPCR. Patients' 5-year cumulative survival rate was analyzed by Kaplan-Meier curves with the Log rank test. Chi-square test and multivariate Cox regression analysis were used to access the clinical significance. CCK-8 assay, transwell assay, and TUNEL assays were used to monitor the change of cell proliferation, invasion, migration, and apoptosis.
Results: The expression level of LINC01006 was increased while miR-3199 was decreased in colon tissues and cells compared to normal ones. This dysregulated expression was correlated with T stage (P = 0.002) and N stage (P = 0.009). High LINC01006 level (HR = 4.048, 95%: 1.502-10.911, P = 0.006) or low miR-3199 level (HR = 3.421, 95% CI: 1.254-9.330, P = 0.016) was outstanding for predicting poor prognosis in patients with colon cancer. Downregulation of LINC01006 reduced cell proliferation, invasion, and migration but induced cell apoptosis (P < 0.05).
Conclusion: LINC01006 knockdown showed anti-proliferative, anti-metastatic, and apoptotic-induced effects on colon cancer cells. This study contributes to research on promising prognostic biomarkers of colon cancer and might give way to further investigation of alternative tumor targets.
Keywords: LINC01006; colon cancer; miR-3199; prognosis.
© 2022 Wu et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures





Similar articles
-
LINC01006 promotes cell proliferation and metastasis in pancreatic cancer via miR-2682-5p/HOXB8 axis.Cancer Cell Int. 2019 Dec 2;19:320. doi: 10.1186/s12935-019-1036-2. eCollection 2019. Cancer Cell Int. 2019. PMID: 31827394 Free PMC article.
-
LINC01006 regulates the proliferation, migration and invasion of hepatocellular carcinoma cells through regulating miR-433-3p/CBX3 axis.Ann Hepatol. 2021 Nov-Dec;25:100343. doi: 10.1016/j.aohep.2021.100343. Epub 2021 Mar 26. Ann Hepatol. 2021. PMID: 33781916
-
LINC01006 facilitates cell proliferation, migration and invasion in prostate cancer through targeting miR-34a-5p to up-regulate DAAM1.Cancer Cell Int. 2020 Oct 19;20:515. doi: 10.1186/s12935-020-01577-1. eCollection 2020. Cancer Cell Int. 2020. PMID: 33088221 Free PMC article.
-
Upregulation of MiR-1274a is Correlated with Survival Outcomes and Promotes Cell Proliferation, Migration, and Invasion of Colon Cancer.Onco Targets Ther. 2020 Jul 17;13:6957-6966. doi: 10.2147/OTT.S246160. eCollection 2020. Onco Targets Ther. 2020. PMID: 32764986 Free PMC article.
-
Low miR-1273a expression predicts poor prognosis of colon cancer and facilitates tumor cell proliferation, migration, and invasion.Braz J Med Biol Res. 2021 Jan 8;54(2):e10394. doi: 10.1590/1414-431X202010394. eCollection 2021. Braz J Med Biol Res. 2021. PMID: 33439933 Free PMC article.
References
LinkOut - more resources
Full Text Sources